164 related articles for article (PubMed ID: 34089292)
1. Gankyrin activates the hedgehog signalling to drive metastasis in osteosarcoma.
Wang C; Jing J; Hu X; Yu S; Yao F; Li Z; Cheng L
J Cell Mol Med; 2021 Jul; 25(13):6232-6241. PubMed ID: 34089292
[TBL] [Abstract][Full Text] [Related]
2. Gankyrin promotes osteosarcoma tumorigenesis by forming a positive feedback loop with YAP.
Cheng L; Wu B; Zhang L; Bian E; An R; Yu S; Liu W; Xiong Z
Cell Signal; 2020 Jan; 65():109460. PubMed ID: 31678253
[TBL] [Abstract][Full Text] [Related]
3. H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts.
Zhang Y; Liu Z; Yang X; Lu W; Chen Y; Lin Y; Wang J; Lin S; Yun JP
Theranostics; 2021; 11(3):1473-1492. PubMed ID: 33391546
[No Abstract] [Full Text] [Related]
4. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
[TBL] [Abstract][Full Text] [Related]
5. Hedgehog/GLI1 signaling pathway regulates the resistance to cisplatin in human osteosarcoma.
Chen D; Kang X; Li Z; Chen L; Ma Q; Fan P
J Cancer; 2021; 12(22):6676-6684. PubMed ID: 34659557
[No Abstract] [Full Text] [Related]
6. Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity.
Zhen C; Chen L; Zhao Q; Liang B; Gu YX; Bai ZF; Wang K; Xu X; Han QY; Fang DF; Wang SX; Zhou T; Xia Q; Gong WL; Wang N; Li HY; Jin BF; Man JH
Oncogene; 2013 Jul; 32(29):3452-60. PubMed ID: 22890318
[TBL] [Abstract][Full Text] [Related]
7. Degalactotigonin, a Natural Compound from
Zhao Z; Jia Q; Wu MS; Xie X; Wang Y; Song G; Zou CY; Tang Q; Lu J; Huang G; Wang J; Lin DC; Koeffler HP; Yin JQ; Shen J
Clin Cancer Res; 2018 Jan; 24(1):130-144. PubMed ID: 28951519
[No Abstract] [Full Text] [Related]
8. LINC01123 enhances osteosarcoma cell growth by activating the Hedgehog pathway via the miR-516b-5p/Gli1 axis.
Pan X; Tan J; Tao T; Zhang X; Weng Y; Weng X; Xu J; Li H; Jiang Y; Zhou D; Shen Y
Cancer Sci; 2021 Jun; 112(6):2260-2271. PubMed ID: 33837611
[TBL] [Abstract][Full Text] [Related]
9. Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma.
Liu R; Li Y; Tian L; Shi H; Wang J; Liang Y; Sun B; Wang S; Zhou M; Wu L; Nie J; Lin B; Tang S; Zhang Y; Wang G; Zhang C; Han J; Xu B; Liu L; Gong K; Zheng T
Cancer Lett; 2019 Feb; 443():34-46. PubMed ID: 30503555
[TBL] [Abstract][Full Text] [Related]
10. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma.
Umemura A; Itoh Y; Itoh K; Yamaguchi K; Nakajima T; Higashitsuji H; Onoue H; Fukumoto M; Okanoue T; Fujita J
Hepatology; 2008 Feb; 47(2):493-502. PubMed ID: 18161051
[TBL] [Abstract][Full Text] [Related]
11. Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway.
Wang WP; Sun Y; Lu Q; Zhao JB; Wang XJ; Chen Z; Ni YF; Wang JZ; Han Y; Zhang ZP; Yan XL; Li XF
Oncotarget; 2017 Jan; 8(4):5909-5923. PubMed ID: 27992365
[TBL] [Abstract][Full Text] [Related]
12. Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma.
Wang C; Wang Y; Hong T; Cheng B; Gan S; Chen L; Zhang J; Zuo L; Li J; Cui X
Cell Death Dis; 2020 Feb; 11(2):117. PubMed ID: 32051393
[TBL] [Abstract][Full Text] [Related]
13. Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.
Chen J; Bai M; Ning C; Xie B; Zhang J; Liao H; Xiong J; Tao X; Yan D; Xi X; Chen X; Yu Y; Bast RC; Zhang Z; Feng Y; Zheng W
Oncogene; 2016 May; 35(19):2506-17. PubMed ID: 26364616
[TBL] [Abstract][Full Text] [Related]
14. Gankyrin activates IL-8 to promote hepatic metastasis of colorectal cancer.
Bai Z; Tai Y; Li W; Zhen C; Gu W; Jian Z; Wang Q; Lin JE; Zhao Q; Gong W; Liang B; Wang C; Zhou T
Cancer Res; 2013 Jul; 73(14):4548-58. PubMed ID: 23576566
[TBL] [Abstract][Full Text] [Related]
15. A tumor suppressor protein encoded by circKEAP1 inhibits osteosarcoma cell stemness and metastasis by promoting vimentin proteasome degradation and activating anti-tumor immunity.
Zhang Y; Liu Z; Zhong Z; Ji Y; Guo H; Wang W; Chen C
J Exp Clin Cancer Res; 2024 Feb; 43(1):52. PubMed ID: 38383479
[TBL] [Abstract][Full Text] [Related]
16. Gankyrin promotes the proliferation of gastric cancer and is associated with chemosensitivity.
Zeng YC; Sun D; Li WH; Zhao J; Xin Y
Tumour Biol; 2017 Jun; 39(6):1010428317704820. PubMed ID: 28653901
[TBL] [Abstract][Full Text] [Related]
17. The long non-coding RNA Linc-GALH promotes hepatocellular carcinoma metastasis via epigenetically regulating Gankyrin.
Xu X; Lou Y; Tang J; Teng Y; Zhang Z; Yin Y; Zhuo H; Tan Z
Cell Death Dis; 2019 Jan; 10(2):86. PubMed ID: 30692513
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog/Gli1 signaling pathway.
Li M; Guo T; Lin J; Huang X; Ke Q; Wu Y; Fang C; Hu C
J Ethnopharmacol; 2022 Jan; 283():114689. PubMed ID: 34592340
[TBL] [Abstract][Full Text] [Related]
19. Gankyrin-mediated interaction between cancer cells and tumor-associated macrophages facilitates prostate cancer progression and androgen deprivation therapy resistance.
Peng G; Wang C; Wang H; Qu M; Dong K; Yu Y; Jiang Y; Gan S; Gao X
Oncoimmunology; 2023; 12(1):2173422. PubMed ID: 36776524
[TBL] [Abstract][Full Text] [Related]
20. LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/STAT3/Akt pathway.
Song X; Wang J; Zheng T; Song R; Liang Y; Bhatta N; Yin D; Pan S; Liu J; Jiang H; Liu L
Mol Cancer; 2013 Oct; 12(1):114. PubMed ID: 24093956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]